This module will focus on the regulatory framework of medicines and medical devices development and approval in the US, EU, and emerging economies. The module will also cover global initiatives for harmonization (e.g., ICH) and highlight some key topics of interest (e.g., specialized regulatory procedures) and their role in the overall regulatory strategy. Risk management and safety reporting will be evaluated from the vantage point of a medicine’s life cycle.
Module 5
Regulatory Affairs, Drug Safety and Pharmacovigilance
Who Should Apply?
Professionals working in pharmaceutical and biotechnology companies, as it provides critical insights into the regulatory processes and safety aspects that are integral to their roles.
Professionals involved in clinical research and development, including clinical trial managers, clinical research associates, and clinical scientists, gains a comprehensive understanding of the regulatory landscape and safety considerations in drug development.
Employees of government health departments or regulatory agencies can benefit from this module to gain insights into industry practices and international harmonization efforts, which can inform their regulatory decision-making.
Module Benefits
In-Depth Regulatory Knowledge – Participants will acquire a comprehensive understanding of the regulatory frameworks governing medicines and medical devices in the US, EU, and other emerging economies. This knowledge is invaluable for professionals in pharmaceutical, biotech, and medical device industries.
Global Perspective – The module covers global initiatives like the International Conference on Harmonization (ICH), providing insights into international harmonization efforts, which is particularly relevant in today’s interconnected pharmaceutical landscape.
Improved Decision-Making – Participants will be better equipped to make informed decisions related to regulatory strategies, product planning, and risk management in pharmaceutical development.
Strategic Thinking – The module encourages participants to think strategically about regulatory affairs, which is critical for maximizing the likelihood of regulatory agency approval for new pharmaceutical products.
Entrepreneurial Insights – For entrepreneurs or investors interested in the pharmaceutical or biotech sectors, this module provides insights into the regulatory challenges and safety considerations that can impact business decisions.
Prerequisites, Schedule, and Time Commitment
Prerequisites
A computer and reliable internet to access the online classroom
- Proficiency in English: As this module is conducted in English, participants should have a strong command of the English language, both written and spoken, to effectively comprehend and communicate complex clinical trial concepts.
- Basic Understanding of Pharmaceutical Science: Participants should have a fundamental understanding of pharmaceutical science, including concepts related to drug development, pharmacology, and pharmaceutical manufacturing processes.
Expected Commitment
5-12 hours per week
This module consists of:
- An optional one week orientation
- 5 weeks comprised of 10 lessons and 4 live webinars, each lasting approximately 60-90 minutes
- Final week includes the end of module assessment
Timeline
2026 Cohort – June 29 to August 9
- Orientation (optional): June 22 to June 28
- Weeks 1-5: Lessons 1-10, webinars, and student assignments
- Week 6: Assessment
Module Costs
The total tuition for this module is $2500
GMDP Academy’s Faculty
Our programs are taught by world-renowned faculty.